0:00
My name is Jemima Albayda.
I'm an Assistant Professor
at the Johns Hopkins University,
seeing patients
at the Division of Rheumatology,
Myositis Center.
Today, I will give you "An overview
of the Idiopathic
Inflammatory Myopathies".
0:17
Our objectives with this talk
are to describe
the clinical presentation
of the idiopathic
inflammatory myopathies.
To define
the subgroups of myositis.
And present the framework
for current understanding
of classification.
To enumerate
the known antibody associations.
And discuss how they help guide
prognosis and management.
To detail the clinical evaluation
of myositis
and the role of ancillary testing.
And to briefly discuss
treatment strategies.
0:47
The idiopathic
inflammatory myopathies
are a rare group of acquired
autoimmune muscle disorders.
Clinically, they are characterized
by muscle weakness
and by inflammatory cell
infiltrates in the muscle.
Although, it is thought
of as a muscle disorder,
it is quite heterogenous
in presentation
and treatment response.
Extramuscular manifestations
are often seen
and can include skin
and lung inflammation,
joint, heart,
and rarely GI tract involvement.
There's also a known increased risk
of malignancy,
particularly,
in cases of dermatomyositis.
